PRECISION (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer.

Brief description of study

If you have been diagnosed with breast cancer and are between the ages of 50 years and 75 years old, you may qualify for this study. The main goal of this study is to determine whether certain patients between the ages of 50 and 75 can safely omit radiation treatment after having a lumpectomy (surgery to remove cancer tissue from the breast) by using the investigational test Prosigna PAM-50 to attempt to identify which patients may not need radiation.


Clinical Study Identifier: s16-02300
ClinicalTrials.gov Identifier: NCT02653755
Principal Investigator: Carmen A. Perez
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.